Cinzia Marchese
Overview
Explore the profile of Cinzia Marchese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
2279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerini G, Traversa A, Cece F, Cassandri M, Pontecorvi P, Camero S, et al.
Cells
. 2025 Jan;
14(2).
PMID: 39851564
Adipose-derived mesenchymal stem cells (ASCs) are commonly employed in clinical treatment for various diseases due to their ability to differentiate into multi-lineage and anti-inflammatory/immunomodulatory properties. Preclinical studies support their use...
2.
Traversa A, Mari E, Pontecorvi P, Gerini G, Romano E, Megiorni F, et al.
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337653
Micro/nanoplastics (MNPs), which are widely spread in the environment, have gained attention because of their ability to enter the human body mainly through ingestion, inhalation, and skin contact, thus representing...
3.
Cassandri M, Porrazzo A, Pomella S, Noce B, Zwergel C, Aiello F, et al.
Cell Death Discov
. 2024 Aug;
10(1):351.
PMID: 39107280
Radiotherapy (RT) plays a critical role in the management of rhabdomyosarcoma (RMS), the prevalent soft tissue sarcoma in childhood. The high risk PAX3-FOXO1 fusion-positive subtype (FP-RMS) is often resistant to...
4.
Camero S, Milazzo L, Vulcano F, Ceccarelli F, Pontecorvi P, Pedini F, et al.
BMC Cancer
. 2024 Jul;
24(1):814.
PMID: 38977944
Background: Despite a multimodal approach including surgery, chemo- and radiotherapy, the 5-year event-free survival rate for rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in childhood, remains very poor for...
5.
Leopizzi M, Mundo L, Messina E, Campolo F, Lazzi S, Angeloni A, et al.
Blood
. 2023 Oct;
143(5):429-443.
PMID: 37847858
Hematological malignancies such as Burkitt lymphoma (BL), Hodgkin lymphoma (HL), and diffuse large B-cell lymphoma (DLBCL) cause significant morbidity in humans. A substantial number of these lymphomas, particularly HL and...
6.
Pace A, Scirocchi F, Napoletano C, Zizzari I, Po A, Megiorni F, et al.
J Transl Med
. 2023 Sep;
21(1):626.
PMID: 37715207
Background: Fibroblast growth factor receptor (FGFR) gene family alterations are found in several cancers, indicating their importance as potential therapeutic targets. The FGFR-tyrosine kinase inhibitor (TKI) pemigatinib has been introduced...
7.
Pontecorvi P, Ceccarelli S, Cece F, Camero S, Lotti L, Niccolai E, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511139
The global rise of single-use throw-away plastic products has elicited a massive increase in the nano/microplastics (N/MPLs) exposure burden in humans. Recently, it has been demonstrated that disposable period products...
8.
Arena A, Romeo M, Focaccetti C, Anastasiadou E, Trivedi P, Cifaldi L, et al.
Br J Haematol
. 2023 Feb;
201(2):e12-e15.
PMID: 36775956
No abstract available.
9.
Vaccaro S, Rossetti A, Porrazzo A, Camero S, Cassandri M, Pomella S, et al.
Front Pharmacol
. 2022 Dec;
13:1071176.
PMID: 36532747
Treatment of rhabdomyosarcoma (RMS), the most common a soft tissue sarcoma in childhood, provides intensive multimodal therapy, with radiotherapy (RT) playing a critical role for local tumor control. However, since...
10.
Pomella S, Porrazzo A, Cassandri M, Camero S, Codenotti S, Milazzo L, et al.
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362070
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood and adolescence that includes FP-RMS, harboring the fusion oncoprotein PAX3/7-FOXO1 and FN-RMS, often mutant in the RAS pathway. Risk...